2 x 20 minute presentations and followed by Q&A regarding biofilms in bacterial infections.


  • What is biofilm?
  • Where is it formed?
  • What are the implications of biofilm in these areas?
  • The incidence and prevalence of biofilm infection in the UK and across Europe
  • The differences between naïve and mature biofilm and its impact
  • What is the issue regarding treating biofilm-based infection with antimicrobials?
  • What current guidance and evidence is in the public domain regarding mono and dual therapy antibacterial use with regards to biofilm?
  • What strategies should we apply to overcome barriers regarding biofilm within the Covid environment?
  • A case study regarding a respiratory infection - is biofilm in the forefront of my mind?
  • A relevant second case study where the audience are asked what they would do?
  • Q&A


Any physician or pharmacist involved in treating severe infections.


Professor Gordon Ramage, Microbiologist, University of Glasgow, School of Medicine, Dentistry & Nursing.

For more information, please contact: brian.jones@advanzpharma.com

  • 16:00 - 24/06/2021 to 17:00 - 24/06/2021
  • United Kingdom